title: RE: Aspirin and COX-2 Inhibitor Use in Patients With Stage III Colon Cancer.
authors.affiliation: Walter and Eliza Hall Institute of Medical Research (PG), Department of Medical Oncology (ML), The Royal Melbourne Hospital, Kensington, Vic, Australia. margaret.mwlee@gmail.com.
authors.forename: Margaret
authors.initials: M
authors.lastname: Lee
authors.affiliation: Walter and Eliza Hall Institute of Medical Research (PG), Department of Medical Oncology (ML), The Royal Melbourne Hospital, Kensington, Vic, Australia.
authors.forename: Peter
authors.initials: P
authors.lastname: Gibbs
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001241:Aspirin / Q000008:administration & dosage*; D003110:Colonic Neoplasms / Q000473:pathology* / Q000517:prevention & control*; D052246:Cyclooxygenase 2 Inhibitors / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D001241:Aspirin